March 12, 2026 04:19 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Supreme Court allows first-ever passive euthanasia for 32-year-old man in coma for 13 years | As Iran-US war disrupts global gas supply, India issues guidelines to manage shortages | LPG crisis hits metros: Commercial cylinder shortage triggers panic as govt prioritises domestic supply | Iran war disrupts LPG supplies, restaurants in major Indian cities edge towards shutdown | ‘How dare you question judicial officers?’: SC raps Bengal SIR pleas, orders appellate tribunals for voter list appeals | 'Book withdrawn': NCERT apologises for controversial judiciary chapter after Supreme Court ban | Indian stock market surges as Brent crude dips below $100 after Trump’s Iran remarks | Australia grants asylum to five Iranian women footballers after anthem protest; Albanese says ‘they are safe here’ | Trump administration labels Afghanistan ‘state sponsor of wrongful detention’ | Trump threatens Iran with ‘20 times harder’ strike if oil flow through Strait of Hormuz is disrupted
Covishield

Good scientific decision: Adar Poonawalla on increase in gap between Covishield doses

| @indiablooms | May 14, 2021, at 01:05 am

New Delhi/IBNS: Adar Poonawalla, the CEO of Serum Institute of India (SII) that manufactures anti-Covid-19 vaccine Covishield, has welcomed the central government's decision to increase the gap between the first and second doses of the vaccine to 12-16 weeks.

The Covid Working Group chaired by Dr N K Arora had recommended an extension of the gap between the first and second doses of Covishield vaccine to 12-16 weeks.

In an interview with English news channel NDTV, Poonawalla reacted, "This is beneficial both from the efficacy and the immunogenicity standpoint. This is a very good move because this is based on data that the government received on the basis of which they made a good scientific decision to increase the gap."
 

This is the second time in three months the gap between the doses of Covishield has been increased.

In March, the states and union territories were asked to increase the gap from 28 days to six-eight weeks for "better results".

The increase in the gap between the two doses came at a time India, which is known for its vaccine productions, is facing an acute shortage of vaccines in the face of a massive spike in Covid-19 cases.

However, no change has been recommended by the panel for the other vaccine available in India, Bharat Biotech's Covaxin.

Congress slams Modi government

Congress, which is already cornering the Narendra Modi government over its handling of the second wave of Covid-19, have slammed the Centre for repeatedly changing the interval time between the two doses.

Congress leader Jairam Ramesh tweeted, "First, it was 4 weeks for the 2nd dose, then 6-8 weeks and now we are told 12-16 weeks. Is this because there are not enough stocks of the vaccines for all who are eligible or because professional scientific advice says so? Can we expect some transparency from the Modi Govt?"

Congress MP Shashi Tharoor tweeted, "Govt panel's announcement of 12-16 weeks between Covishield shots follows the UK recommending 8-12 weeks in Dec & @WHO saying 8-12 weeks in Feb. GOI had first decreed 4 weeks, then 6-8 weeks. Could GOI pls explain to the public the science behind their 12-16 weeks recommendation?"

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.